YK Kim - Chonnam medical journal, 2020 - ncbi.nlm.nih.gov
Recent studies identified diverse RNAs including noncoding RNAs and their various action mechanisms in the cells. These RNAs regulate a variety of cellular pathways and are …
YK Kim - Experimental & Molecular Medicine, 2022 - nature.com
RNA therapy refers to the treatment or prevention of diseases using RNA-based molecules. The recent advent of a series of effective messenger RNA-based vaccines in response to the …
ABSTRACT RNA-based therapeutics are emerging as a powerful platform for the treatment of multiple diseases. Currently, the two main categories of nucleic acid therapeutics …
A Curreri, D Sankholkar, S Mitragotri… - Bioengineering & …, 2023 - Wiley Online Library
Ribonucleic acid (RNA) therapeutics are being actively researched as a therapeutic modality in preclinical and clinical studies. They have become one of the most ubiquitously …
Y Weng, H Xiao, J Zhang, XJ Liang, Y Huang - Biotechnology advances, 2019 - Elsevier
Abstract Recently, United States Food and Drug Administration (FDA) and European Commission (EC) approved Alnylam Pharmaceuticals' RNA interference (RNAi) therapeutic …
The growing knowledge on several classes of non-coding RNAs (ncRNAs) and their different functional roles has aroused great interest in the scientific community. Beyond the …
Recent advances of biological drugs have broadened the scope of therapeutic targets for a variety of human diseases. This holds true for dozens of RNA-based therapeutics currently …
J Chery - Postdoc journal: a journal of postdoctoral research and …, 2016 - ncbi.nlm.nih.gov
RNA therapeutics refers to the use of oligonucleotides to target primarily ribonucleic acids (RNA) for therapeutic efforts or in research studies to elucidate functions of genes …
H Shin, SJ Park, Y Yim, J Kim, C Choi… - Advanced …, 2018 - Wiley Online Library
Recently, there have been significant advances in the field of RNA‐based therapeutics harnessing exogenous RNAs including small interfering RNA (siRNA), microRNA (miRNA) …